OrthoAccel Technologies Receives $9,000,000 New Financing

  • Feed Type
  • Date
    1/23/2014
  • Company Name
    OrthoAccel Technologies
  • Mailing Address
    6575 West Loop South Bellaire, TX 77401
  • Company Description
    The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption. FDA will be reviewing the AcceleDent System, which is regulated as a medical device. If clearance is granted, the product will be available at an orthodontist near you.
  • Website
    http://www.orthoaccel.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $9,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    We expect 2014 to be a year of significant growth as we continue to expand our market presence in the United States and other key markets. The additional financing will provide critical resources towards that objective.
  • M&A Terms
  • Venture Investor
    HealthpointCapital Partners
  • Venture Investor
    S3 Ventures
  • Venture Investor
    Comerica Bank

By posting a comment, you agree to our terms and conditions.